SNT Gatchaman
Senior Member
- Messages
- 302
- Location
- New Zealand
Therapeutics are a long way out of my expertise. I read that nattokinase works against plasminogen activator inhibitor 1 and so promotes fibrinolysis. The micro-clots were said to contain anti-plasmin 2 as the anti-fibrinolysis factor, so that may not be the right target. Additionally, there are 3 platelet receptors they are taking aim at, each promoting platelet activation.
According to the video, these platelet receptors of interest are Col/EPI, Col/ADP and GP IIb/IIIa.
Someone with expertise would have to take this further, but I was interested to note that two of those receptors relate to collagen. I think that is the collagen you would find exposed by damaged endothelium. Is that the link with EDS? Does vascular collagen over-activate platelets and set patients up for ME? Can't wait to read the final summary paper when all of this is put together...
According to the video, these platelet receptors of interest are Col/EPI, Col/ADP and GP IIb/IIIa.
Someone with expertise would have to take this further, but I was interested to note that two of those receptors relate to collagen. I think that is the collagen you would find exposed by damaged endothelium. Is that the link with EDS? Does vascular collagen over-activate platelets and set patients up for ME? Can't wait to read the final summary paper when all of this is put together...